Gender Differences in Prolonged Mechanical Ventilation Patients - A Retrospective Observational Study.

Background: The gender differences in patients requiring prolonged mechanical ventilation are not understood. We investigated the effects of gender differences in terms of age, causes of respiratory failure, discharge status, successful weaning, mortality rate and long-term survival outcomes in patients receiving prolonged mechanical ventilation.
Methods: We conducted a six-year retrospective study of patients requiring prolonged mechanical ventilation. Survival curves for all patients requiring prolonged mechanical ventilation and those who were very old (aged ≥ 80 years) were compared based on gender.
Results: Among the 574 patients enrolled. There was no statistically significant difference between male and female patients regarding successful weaning, ventilator dependence, or in-hospital mortality. We gathered long-term follow-up data on 296 patients, including 70 very old male patients and 41 very old female patients. The 6-month, 3-year, and 5-year mortality rates for the 189 male patients were 75.1%, 85.2%, and 89.9%, respectively; the corresponding rates for the 107 female patients were 66.4%, 86.0%, and 88.8%, respectively. There was no statistically significant difference between two groups regarding mortality rates. The five-year survival curve of male patients was similar to that of female patients. The 6-month, 1-year, and 5-year mortality rates for the 70 very old male patients were 90.0%, 95.7%, and 97.1%, respectively; the corresponding rates for the 41 very old female patients were 63.4%, 90.2%, and 95.1%, respectively. There was a statistically significant difference between very old male and very old female patients in the 6-month mortality rate and the five-year survival curve.
Conclusion: There were no gender differences in weaning status, ventilator dependence, in-hospital mortality, or survival outcomes among patients requiring prolonged mechanical ventilation. Among very old patients requiring prolonged mechanical ventilation, the risk of death was 34% lower in very old female patients than in very old male patients for a period of five years.

Introduction

Men and women differ biologically and in lifestyle factors, such as nutrition, physical activity, work, education, and stress. In many diseases, the incidence, causes, risk factors, clinical presentations, diagnoses, treatments, responses to treatment and prognoses differ significantly between women and men. Gender medicine is a new discipline that explores gender influences on the pathophysiology, clinical symptoms and signs, prevention, therapy and prognosis of diseases. The development of gender-specific medicine is important to understand the differences in the prevention, care, treatment, and outcomes of diseases in both genders. The aim of gender medicine is to recognize the differences arising from gender in several aspects, including anatomical, physiological, biological, functional, and social aspects, as well as the response between genders to pharmacological treatment.1 Many studies discuss gender differences in medical diseases such as cancer, coronary heart disease, diabetes mellitus, stroke, Alzheimer’s disease, dementia, depression, chronic kidney disease, liver disease, and autoimmune disease.2–18 The studies discussing gender differences in pulmonary diseases have mainly focused on asthma, cancer, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and tuberculosis.19–26 The extent of gender differences in disease cause, course, and prognosis in patients on prolonged mechanical ventilation (PMV) is unknown and may vary based on many factors. The purpose of this study was to investigate the effects of gender differences according to age, causes of respiratory failure leading to PMV, comorbidities, respiratory care center (RCC; a weaning unit within an acute-care hospital) discharge status, successful weaning, mortality rate and long-term survival outcomes in patients with PMV in a RCC.

Methods

Details of the Hospital

The Dalin Tzu Chi Hospital is a tertiary-level teaching hospital with 600 acute-care beds and an intensive care unit (ICU) containing 59 beds. A 10-bed ventilator weaning unit (RCC) is available within Dalin Tzu Chi Hospital (an acute-care hospital), and this unit provides care for patients on PMV.

Patient Details

We conducted a retrospective single-center study and enrolled all patients consecutively admitted to the RCC of Dalin Tzu Chi Hospital between January 1, 2012, and December 31, 2017. Patients included those who received PMV for >21 days and patients who were eligible for RCC admission if they met the Taiwan National Health Insurance requirements.27

The long-term survival of all participants was calculated from the date of admission to the RCC until death or December 31, 2021. We collected data on all patients requiring PMV, including age, gender, comorbidities, causes of acute respiratory failure leading to PMV, receipt or not of tracheostomy, RCC discharge status, weaning status, and long-term outcomes. Data were extracted retrospectively for all participants from their medical records. Survival curves for all patients requiring PMV and for very old (aged ≥ 80 years) patients requiring PMV were compared separately based on gender.

Definition of Outcomes

A PMV patient was defined as using a mechanical ventilator for at least six hours daily for 21 or more consecutive days. A successfully weaned patient was defined as a patient who was independent of the ventilator for 5 consecutive days and nights, and these patients were transferred to the general ward for further care. We classified the successfully weaned patients requiring PMV into two groups: (1) ward mortality patients who died in the ward before hospital discharge and (2) discharged PMV patients who discharged from the hospital after weaning from PMV. Ventilator dependence was defined as an inability to be weaned from the ventilator, which necessitated transfer to a long-term care hospital (LTCH) for long-term ventilator support (LTCH is a respiratory care ward in Taiwan). Unsuccessfully weaned patients included patients who died during the RCC hospitalization, hospice patients in the RCC, and ventilator-dependent patients in the LTCH. The in-hospital mortality patients included patients who died during RCC hospitalization, successfully weaned patients who died in the general ward before hospital discharge, and hospice patients in the RCC. Patients aged ≥ 80 years were defined as very old patients.

Causes of acute respiratory failure leading to PMV were classified into the following 11 categories: (1) pneumonia, (2) intracranial hemorrhage, (3) sepsis, (4) postoperative condition, (5) COPD, (6) cardiac disease (including decompensated heart failure, coronary atherosclerotic disease, and acute myocardial infarction), (7) underlying malignant disease, (8) cervical spine disease, (9) postcardio-pulmonary-cerebral resuscitation (CPCR) hypoxic encephalopathy, (10) cerebral infarction, and (11) other miscellaneous causes.

Statistical Analysis

Continuous variables are expressed as the mean ± standard deviation or median, whereas categorical variables are expressed as frequencies and percentages. The differences in baseline characteristics, causes of acute respiratory failure, RCC discharge status, weaning status, the receipt or not of tracheostomy, and comorbidities were evaluated using Student’s t test for continuous variables and Pearson’s chi-square test or Fisher’s exact test for categorical variables. The differences in 6-month, 1-year, 3-year and 5-year mortality rates were evaluated using Fisher’s exact test between male and female patients requiring PMV. Univariate analysis was used to analyze differences in variables for male and female patients requiring PMV. Multivariate stepwise logistic regression models were used to evaluate the impact of each variable in male and female patients requiring PMV. Kaplan–Meier method was used to estimate the cumulative probability of survival as a function of the number of months in log-term follow-up male patients requiring PMV and long-term follow-up female patients requiring PMV. The Log rank test was used to compare survival rates between the two groups. Cox proportional hazards models were used to determine whether there was a relationship between the survival rates of the two groups. The Kaplan–Meier method was also used to estimate the cumulative probability of survival as a function of the number of months in very old male patients requiring PMV and very old female patients requiring PMV. The Log rank test was used to compare survival rates between the two groups. Cox proportional hazards models were used to determine the relationship between the survival rates of the two groups. All statistical analyses were conducted using the statistical package SPSS for Windows (Version 17.0, SPSS, Inc., Chicago, IL), and a P value<0.05 was considered to show statistical significance.

Results

Over six years, 574 patients were admitted to the RCC (Figure 1). Of these, 357 (62.2%) were men, and 217 (37.8%) were women. Three hundred ninety-one patients (68.1%) were successfully weaned from the ventilator, including 242 men and 149 women.28 The mean age was statistically significantly difference between male and female patients (71.46 vs 73.88 years, P=0.046). Table 1 shows the differences in clinical variables between male and female patients requiring PMV. There was no statistically significant difference between male and female patients in successful weaning, ventilator dependence, RCC mortality, general ward mortality, or in-hospital mortality. In terms of comorbidities, there was a statistically significant difference between male and female patients only for cardiovascular comorbidities. In terms of causes of respiratory failure leading to PMV, sepsis and cardiac disease were reported more often in female patients, and pneumonia was reported more often in male patients. A multivariate analysis between male and female patients requiring PMV showed that sepsis and cardiac disease were statistically significant difference between two groups (Table 2).

Figure 1

Flow chart of 574 prolonged mechanical ventilation patients. Five hundred and seventy-four prolonged mechanical ventilation patients enrolled. We gathered long-term follow-up data on 296 patients, including 70 very old male patients and 41 very old female patients.

Table 1

Comparison of Clinical Variables Between Male and Female in 574 PMV Patients

	Male	Female	P	OR
	(N=357)	(N=217)
Successfully weaned, No (%)	242(67.8%)	149(68.7%)	0.854	0.960
Ventilator-dependent, No (%)	55(15.4%)	28(12.9%)	0.463	1.229
RCC mortality, No (%)	59(16.5%)	36(16.6%)	1.000	0.995
Ward mortality, No (%)	51(14.3%)	35(16.1%)	0.549	0.867
In-hospital mortality, No (%)	113(31.7%)	73(33.6%)	0.646	0.914
Age Groups, No (%)
Age <45 Y/O	11(3.1%)	6(2.8%)	1.000	1.118
Age 45–54 Y/O	36(10.1%)	17(7.8%)	0.457	1.319
Age 55–64 Y/O	54(15.1%)	22(10.1%)	0.099	1.580
Age 65–74 Y/O	79(22.1%)	39(18.0%)	0.243	1.297
Age 75–84 Y/O	122(34.2%)	89(41.0%)	0.108	0.747
Age ≥85 Y/O	55(15.4%)	44(20.3%)	0.140	0.716
Causes of respiratory failure
Pneumonia	142(39.8%)	67(30.9%)	0.032	1.479
Intracranial hemorrhage	68(19.1%)	41(18.9%)	1.000	1.010
Sepsis	22(6.2%)	31(14.3%)	0.002	0.394
COPD	23(6.4%)	8(3.7%)	0.185	1.799
Cardiac disease	13(3.6%)	18(8.3%)	0.022	0.418
Malignant disease	12(3.4%)	9(4.1%)	0.651	0.804
Post operation	24(6.7%)	15(6.9%)	0.930	0.971
Cervical-spine disease	10(2.8%)	1(0.5%)	0.059	6.225
Post-CPCR	6(1.7%)	5(2.3%)	0.755	0.725
Cerebral infarction	8(2.2%)	2(0.9%)	0.333	2.464
Miscellaneous causes	29(8.1%)	20(9.2%)	0.647	0.871
Comorbidity
Cardiovascular disease, No (%)	214(59.9%)	156(71.9%)	0.004	0.585
Chronic lung disease, No (%)	70(19.6%)	30(13.8%)	0.089	1.520
Chronic kidney disease, No (%)	35(9.8%)	27(12.4%)	0.334	0.765
End-stage renal disease, No (%)	28(7.8%)	16(7.4%)	0.873	1.069
Neurologic disease, No (%)	120(33.6%)	69(31.8%)	0.714	1.086
Metabolic disease, No (%)	118(33.1%)	88(40.1%)	0.073	0.724
Malignant disease, No (%)	58(16.2%)	23(10.6%)	0.064	1.636
Liver disease, No (%)	35(9.8%)	15(6.9%)	0.236	1.464

Abbreviations: PMV, prolonged mechanical ventilation; No, number; RCC, respiratory care center; COPD, chronic obstructive pulmonary disease; CRCP, Cardio-Pulmonary-Cerebral-Resuscitation; Y/O, years old.

Table 2

Difference in Clinical Characteristics Variables Between Male and Female in 574 Prolonged Mechanical Ventilation Patients

	Odds Ratios	95% Confidence	P
Multivariate analysis
Successfully weaned	0.862	0.583–1.276	0.458
Age 45–54 Y/O	1.282	0.395–4.158	0.679
Age 55–64 Y/O	1.383	0.440–4.350	0.579
Age 65–74 Y/O	1.355	0.436–4.093	0.613
Age 75–84 Y/O	0.769	0.257–2.304	0.639
Age ≥85 Y/O	0.639	0.204–1.998	0.441
Causes of respiratory failure
Pneumonia	1.195	0.672–2.126	0.544
Intracranial hemorrhage	1.109	0.598–2.058	0.742
Sepsis	0.396	0.185–0.849	0.017
COPD	1.321	0.476–3.666	0.592
Cardiac disease	0.376	0.156–0.911	0.030
Malignant disease	0.532	0.185–1.527	0.241
Post operation	0.948	0.418–2.152	0.899
Comorbidity
Cardiovascular disease	0.841	0.559–1.265	0.405
Chronic lung disease	1.405	0.815–2.423	0.221
Chronic kidney disease	0.931	0.515–1.684	0.813
End-stage renal disease	1.591	0.776–3.260	0.205
Neurologic disease	1.255	0.839–1.876	0.269
Metabolic disease	0.800	0.542–1.181	0.261
Malignant disease	1.333	0.750–2.370	0.327
Liver disease	1.479	0.765–2.860	0.244

Abbreviations: COPD, chronic obstructive pulmonary disease; Y/O, years old.

We further gathered long-term follow-up data on 296 patients requiring PMV up to December 31, 2021. Of these, 189 (63.9%) were men, and 107 (36.1%) were women. In terms of comorbidities, there was a statistically significant difference between male and female patients for malignant disease. In terms of causes of respiratory failure leading to PMV, sepsis was reported more often in female patients, and pneumonia was reported more often in male patients (Table 3). A multivariate analysis between long-term follow-up male patients requiring PMV and long-term follow-up female patients requiring PMV showed there was no statistically significant difference between two groups (Table 4). The 6-month, 1-year, 3-year, and 5-year mortality rates for the 189 male patients were 75.1%, 80.4%, 85.2%, and 89.9%, respectively; the corresponding rates for the 107 female patients were 66.4%, 78.5%, 86.0%, and 88.8%, respectively. There was no statistically significant difference between male and female patients in any of the above mortality rates. Kaplan–Meier analysis showed that the five-year survival curve of male patients requiring PMV was similar to that of female patients requiring PMV (P = 0.477; Log rank test). According to a Cox proportional hazards regression analysis of the 296 patients requiring PMV, no factors were determined to be related to survival in male patients or female patients (Figure 2).

Table 3

Comparison of Clinical Variables Between Male and Female in 296 Long-Term Follow-Up Prolonged Mechanical Ventilation Patients

	Male	Female	P	Odd Ratio
	(N=189)	(N=107)
Successfully weaned, No (%)	109(57.7%)	70(65.4%)	0.191	0.720
Tracheostomy, No (%)	29(15.3%)	16(15.0%)	0.928	1.031
Age Groups, No (%)
Age <45 Y/O, No (%)	2(1.1%)	4(3.7%)	0.140	0.275
Age 45–54 Y/O, No (%)	20(10.6%)	9(8.4%)	0.547	1.289
Age 55–64 Y/O, No (%)	27(14.3%)	6(5.6%)	0.028	2.806
Age 65–74 Y/O, No (%)	41(21.7%)	22(20.6%)	0.819	1.070
Age 75–84 Y/O, No (%)	68(36.0%)	46(43.0%)	0.234	0.745
Age ≥85 Y/O, No (%)	31(16.4%)	20(18.7%)	0.617	0.853
Causes of respiratory failure
Pneumonia, No (%)	80(42.3%)	24(22.4%)	0.001	2.538
Intracranial hemorrhage, No (%)	28(14.8%)	20(18.7%)	0.386	0.757
Sepsis, No (%)	17(9.0%)	20(18.7%)	0.017	0.430
COPD, No (%)	13(6.9%)	6(5.6%)	0.669	1.243
Cardiac disease, No (%)	10(5.3%)	10(9.3%)	0.187	0.542
Malignant disease, No (%)	10(5.3%)	6(5.6%)	0.908	0.940
Post operation, No (%)	10(5.3%)	10(9.3%)	0.187	0.542
Comorbidity
Cardiovascular disease, No (%)	117(61.9%)	77(72.0%)	0.081	0.633
Chronic lung disease, No (%)	39(26.6%)	20(18.7%)	0.668	1.131
Chronic kidney disease, No (%)	19(10.1%)	16(15.0%)	0.212	0.636
End-stage renal disease, No (%)	17(9.0%)	8(7.5%)	0.652	1.223
Neurologic disease, No (%)	59(31.2%)	35(32.7%)	0.791	0.934
Metabolic disease, No (%)	70(37.0%)	43(40.2%)	0.592	0.876
Malignant disease, No (%)	39(20.6%)	11(10.3%)	0.025	2.269
Liver disease, No (%)	18(9.5%)	7(6.5%)	0.378	1.504

Abbreviations: COPD, chronic obstructive pulmonary disease; Y/O, years old; No, number.

Table 4

Difference in Clinical Characteristics Variables Between Male and Female in 296 Long-Term Follow-Up Prolonged Mechanical Ventilation Patients

	Odds Ratios	95% Confidence	P
Multivariate analysis
Successfully weaned	0.667	0.381–1.168	0.157
Tracheostomy	1.165	0.551–2.464	0.690
Age 45–54 Y/O	3.272	0.457–23.399	0.238
Age 55–64 Y/O	6.929	0.913–52.567	0.061
Age 65–74 Y/O	3.476	0.522–23.150	0.198
Age 75–84 Y/O	0.439	0.068–2.821	0.386
Age ≥85 Y/O	0.501	0.075–3.363	0.477
Causes of respiratory failure
Pneumonia	2.073	0.817–5.258	0.125
Intracranial hemorrhage	0.762	0.277–2.093	0.598
Sepsis	0.392	0.138–1.109	0.077
COPD	1.195	0.305–4.681	0.798
Cardiac disease	0.609	0.183–2.025	0.418
Malignant disease	0.517	0.122–2.190	0.371
Post operation	1.195	0.202–2.277	0.530
Comorbidity
Cardiovascular disease	0.795	0.435–1.452	0.455
Chronic lung disease	1.098	0.517–2.331	0.808
Chronic kidney disease	0.914	0.408–2.046	0.827
End-stage renal disease	1.604	0.606–4.244	0.341
Neurologic disease	0.995	0.557–1.779	0.987
Metabolic disease	0.852	0.489–1.486	0.530
Malignant disease	1.896	0.786–4.569	0.154
Liver disease	1.874	0.697–5.037	0.213

Abbreviations: COPD, chronic obstructive pulmonary disease; Y/O, years old.

Figure 2

Kaplan–Meier survival curves of 296 patients receiving prolonged mechanical ventilation base on gender. Comparisons by gender of 296 patients receiving prolonged mechanical ventilation (P = 0.477: Log rank test). According to Cox proportional hazards regression analysis of the 296 prolonged mechanical ventilation patients showed that no factors were determined to be related to survival in male patients or female patients.

These 296 patients requiring PMV included 70 very old male patients and 41 very old female patients. In terms of comorbidities, malignant disease was reported more often in very old male patients (Table 5). A multivariate analysis between very old male patients and very old female patients showed that only malignancy comorbidity was statistically significantly difference between two groups (Table 6). The 6-month, 1-year, 3-year, and 5-year mortality rates for the 70 very old male patients were 90.0%, 92.9%, 95.7%, and 97.1%, respectively; the corresponding rates for the 41 very old female patients were 63.4%, 80.5%, 90.2%, and 95.1%, respectively. A statistically significant difference between very old male patients and very old female patients was found only in the 6-month mortality rate (P=0.001, odds ratio (OR)=5.192). Kaplan–Meier analysis showed a statistically significant difference in survival between very old male patients and very old female patients (P = 0.038; Log rank test). According to Cox proportional hazards regression analysis of the 111 very old patients requiring PMV, the risk of death was 34% lower in the very old female patients than in the very old male patients (P = 0.045; hazard ratio (HR) = 0.66; 95% confidence interval (CI) 0.442–0.991) (Figure 3).

Table 5

Comparison of Clinical Variables Between Male and Female in 111 Very Old Long-Term Follow-Up Prolonged Mechanical Ventilation Patients

	Male	Female	P	Odd Ratio
	(N=70)	(N=41)
Successfully weaned, No (%)	34(48.6%)	27(65.9%)	0.790	0.490
Tracheostomy, No (%)	5(7.1%)	5(12.2%)	0.375	0.554
Cause of respiratory failure
Pneumonia, No (%)	37(44.3%)	16(39.0%)	0.161	1.752
Intracranial hemorrhage, No (%)	5(7.1%)	4(9.8%)	0.628	0.712
Sepsis, No (%)	6(8.6%)	5(12.2%)	0.539	0.675
COPD, No (%)	6(8.6%)	3(7.3%)	0.815	1.187
Cardiac disease, No (%)	2(2.9%)	3(7.3%)	0.291	0.373
Malignant disease, No (%)	3(4.3%)	1(2.4%)	0.619	1.791
Post operation, No (%)	6(8.6%)	4(9.8%)	0.833	0.867
Comorbidity
Cardiovascular disease, No (%)	47(67.1%)	32(78.0%)	0.224	0.575
Chronic lung disease, No (%)	19(27.1%)	11(26.8%)	0.971	1.016
Chronic kidney disease, No (%)	12(17.1%)	10(24.4%)	0.357	0.641
End-stage renal disease, No (%)	5(7.1%)	1(2.4%)	0.313	3.077
Neurologic disease, No (%)	29(41.4%)	17(41.5%)	0.997	0.999
Metabolic disease, No (%)	24(34.3%)	18(43.9%)	0.314	0.667
Malignant disease, No (%)	14(20.0%)	1(2.4%)	0.029	10.000
Liver disease, No (%)	5(7.1%)	1(2.4%)	0.313	3.007

Abbreviations: COPD, chronic obstructive pulmonary disease; Y/O, years old; No, number.

Table 6

Difference in Clinical Characteristics Variables Between Male and Female in 111very Old Long-Term Follow-Up Prolonged Mechanical Ventilation Patients

	Odds Ratios	95% Confidence	P
Multivariate analysis
Successfully weaned	0.448	0.173–1.160	0.098
Tracheostomy	0.351	0.071–1.727	0.198
Causes of respiratory failure
Pneumonia	3.326	0.685–16.141	0.136
Intracranial hemorrhage	0.542	0.065–4.525	0.572
Sepsis	0.622	0.075–5.187	0.661
COPD	2.638	0.257–27.108	0.414
Cardiac disease	0.536	0.046–6.249	0.619
Malignant disease	1.048	0.034–32.489	0.979
Post operation	0.515	0.064–4.128	0.532
Comorbidity
Cardiovascular disease	0.688	0.229–2.069	0.505
Chronic lung disease	1.247	0.337–4.607	0.741
Chronic kidney disease	0.696	0.204–2.368	0.561
End-stage renal disease	7.676	0.660–89.258	0.103
Neurologic disease	0.870	0.321–2.357	0.784
Metabolic disease	0.502	0.174–1.445	0.202
Malignant disease	16.563	1.166–235.227	0.038
Liver disease	4.618	0.400–53.358	0.220

Abbreviation: COPD, chronic obstructive pulmonary disease.

Figure 3

Kaplan–Meier survival curves of 111 very old patients receiving prolonged mechanical ventilation base on gender. Comparisons by gender of 111 very old patients receiving prolonged mechanical ventilation (P = 0.038: Log rank test). Cox proportional hazards regression analysis of the 111 very old prolonged mechanical ventilation patients showed that the risk of death was 34% lower of those very old female patients than those very old male patients (P = 0.045; HR = 0.66; 95% CI 0.442–0.991).

Discussion

We did not find any studies in the international literature related to gender differences in patients requiring PMV. To our knowledge, this study is the only study to focus on gender differences in patients requiring PMV in the literature. Therefore, we can analyze only our research results, and we hope that these results can inspire similar research.

There were 256 (71.7%) male patients requiring PMV aged ≥ 65 years and 172 (79.3%) female patients requiring PMV aged ≥ 65 years (P=0.048, OR= 0.663). Therefore, the mean age of women was older than that of men in our study. In a study by Corrao et al, a retrospective observational study included 1380 hospitalized elderly patient. Coronary artery disease was more frequent in men, but hypertension was more frequent in women.29 Motiejunaite et al demonstrated that hypertension was more frequent in women in the studies of 22,523 acute heart failure patients.30 There were 35 cases (9.8%) of coronary artery disease in male patients requiring PMV and 12 cases (5.5%) of coronary artery disease in female patients requiring PMV (P=0.084, OR=1.857). There were 166 cases (46.5%) of hypertension in male patients requiring PMV and 134 cases (61.8%) of hypertension in female patients requiring PMV (P<0.001, OR=0.538, 95% CI 0.382–0.759). The comparison of the clinical demographic profiles between male and female patients requiring PMV showed more cardiovascular comorbidities in female patients requiring PMV in our study, similar to the literature. The analysis of causes of respiratory failure leading to PMV showed gender differences in pneumonia, sepsis and cardiac disease. Female patients had more cardiovascular comorbidities resulting in more respiratory failure secondary to cardiac disease. There were 3 cases (0.8%) of urosepsis in male patients and 10 cases (4.6%) of urosepsis in female patients (P=0.006, OR=0.175, 95% CI 0.048–0.645). Female patients have a higher risk of urinary tract infection than male patients. Among women aged 18 years and older, the estimated incidence was 12.6%; for men, this incidence was only 3%.31 Female patients have a higher risk of urinary tract infection than male patients. This clinical phenomenon explains why there were more urosepsis cases in female patients in this study. Some studies showed that the male gender was associated with an increased risk of pneumonia.32–35 In our patients requiring PMV, we found that pneumonia was predominant in males as the cause of respiratory disease.

In this study, RCC discharge statuses, including successful weaning, ventilator dependence, and in-hospital mortality, were similarly distributed across both genders. This finding means that there was no statistically significant difference in short-term outcomes between male and female patients requiring PMV. In terms of long-term survival outcomes, there was no statistically significant difference in five-year survival outcomes between male and female patients requiring PMV. Few studies have explored very old patients requiring PMV.36–38 These studies mainly focused on the clinical characteristics, weaning outcomes and long-term outcomes of patients requiring PMV. No study discusses gender differences in long-term survival outcomes. We explored whether there were gender differences in long-term survival outcomes in very old patients requiring PMV. There were 14 cases (20.0%) of malignancy comorbidity in very old male patients requiring PMV and 1 case (2.4%) of malignancy comorbidity in very old female patients requiring PMV (P=0.029, OR=10.00, 95% CI 1.263–79.164). Very old male patients were more number of malignancy comorbidity patients than very old female patient. A comparison of very old patients requiring PMV between males and females with 6-month mortality rate showed that there was a statistically significant difference between two groups (P=0.001, OR= 5.192). The 5-year survival rate analysis showed that very old male patients requiring PMV had a worse five-year survival rate than very old female patients requiring PMV in our study. The poorer survival outcome of the very old male patients requiring PMV was related to the high 6-month mortality rate and a higher percentage of malignancy comorbidity. The importance of this study is that it is a pioneering report on gender differences in PMV. We hope this study will inspire more medical experts to research gender differences in PMV.

Limitations of Our Study

Our findings on the gender differences in patients requiring PMV must be interpreted with caution since they are derived from a 6-year retrospective single-center study and there is a possibility of changing the management strategy. The gender differences in patients requiring PMV in terms of causes of respiratory failure, clinical characteristics, treatment outcomes, weaning status, and long-term survival outcomes need further prospective study by medical experts in the future. We expect additional studies on gender differences in patients requiring PMV to yield additional insights.

Conclusion

Among all patients requiring PMV, there were no gender differences in terms of weaning status, ventilator dependence, in-hospital mortality or survival outcomes. Among very old (aged ≥ 80 years) patients requiring PMV, very old female patients requiring PMV had better survival outcomes than very old male patients requiring PMV, related to the high 6-month mortality rate and a higher percentage of malignancy comorbidity in very old male patients requiring PMV.